Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Friday, December 4, 2020

Anxiety may help to progress Alzheimer’s disease

 With your massive amount of anxiety because your doctor knows nothing and does nothing to get you 100% recovered, you are screwed. The solution is 100% recovery protocols, NOT GUIDELINES.

Anxiety may help to progress Alzheimer’s disease

The results of a new study presented at the annual meeting of the Radiological Society of North America (RSNA) reveal the link between increased levels of anxiety and an elevated rate of progression to Alzheimer's disease from symptoms of mild cognitive impairment.

Investigating the role of anxiety in the speed of cognitive decline

According to the World Health Organization (WHO), around 50 million people globally suffer from dementia, with almost 10 million new cases arising each year. Statistics show that Alzheimer's disease is the most common form of dementia, accounting for as many as 60–70% of cases. The disease is considered to be a major public health crisis across the globe. With deaths from the disease increasing by two-fold since 2000, new approaches to reducing the detrimental impact of Alzheimer's disease are needed to protect the aging population.

Often, the first stage of Alzheimer's disease is a decline in cognitive function. While cognitive decline is common in the aging population and is not necessarily linked with disease, the speed of decline is accelerated in those with Alzheimer's disease. Additionally, anxiety has also been noted as commonly presenting itself alongside mild cognitive impairment. However, the relationship between the two has not been well-researched.

Researchers at the Medical University of South Carolina (MUSC) designed a study to shed some light on the connection between cognitive decline and anxiety. Maria Vittoria Spampinato, the study’s senior author, explains that "In this study, we wanted to see if anxiety had an effect on brain structure, or if the effect of anxiety was independent from brain structure in favoring the progression of disease.”

Anxiety may speed up cognitive impairment in Alzheimer's disease

A total of 339 patients were recruited in the study. Patients had an average age of 72 years and had a baseline diagnosis of mild cognitive impairment. During the study, a total of 72 patients went on to become diagnosed with Alzheimer's disease.

MRIs of the patients’ brains were analyzed to establish the baseline volumes of two key areas implicated in memory formation, the hippocampus, and the entorhinal cortex. The researchers also determined whether patients had the ApoE4 allele, known to be the most prevalent genetic risk factor for Alzheimer's disease. Additionally, the researchers used clinical surveys to measure anxiety.

The results showed that patients who went on to obtain a diagnosis of Alzheimer's disease were those who had significantly lower hippocampal volumes at the onset of the study. They also had reduced volumes of the entorhinal cortex and were more likely to have the ApoE4 allele. These findings were expected.

The study’s results also revealed that anxiety was independently related to cognitive decline. Those with mild cognitive impairment patients developed Alzheimer's disease at faster rates if they also had symptoms of anxiety, in comparison to those who did not. This effect was observed regardless of if the patient had the genetic risk factor or not.

Anxiety as a cause or effect of cognitive decline?

The study’s researchers were able to highlight a link between symptoms of anxiety and the rate of progression of Alzheimer's disease. These findings, therefore, may be critical to developing new therapeutic approaches to disease prevention in those who have already begun showing signs of cognitive decline.

Spampinato states highlights that first, more research is needed to understand the relationship.

If we were able in the future to find that anxiety is actually causing progression, then we should more aggressively screen for anxiety disorders in the elderly.”

Next, the researchers will focus on investigating whether anxiety is a cause or effect of cognitive decline. They will also explore the impact of gender differences on the relationship between anxiety and cognitive decline.

Source:
 

No comments:

Post a Comment